Skip to content

For laboratory research use only. Not for human or veterinary use.

CJC-1295 WITHOUT DAC

FOR RESEARCH USE ONLYNot for human or veterinary use of any kind

Full label. Lot number and expiry differ per batch and are printed on each vial.

1 / 2

GHRH Analogs & GH SecretagoguesPopular Research Peptides

CJC-1295 without DAC (Mod GRF 1-29)

Also known as: Mod GRF(1-29), Modified GRF 1-29

CJC-1295 without DAC, commonly called modified GRF(1-29), is a synthetic 29-amino-acid GHRH analogue without the albumin-reactive DAC extension. It is supplied as a lyophilized powder for in vitro and analytical research involving peptide identity and GHRH-related signaling.

CAS
446036-97-1 (non-DAC free form)[1]
M.W.
Approximately 3,367.95 g/mol (free peptide)
Formula
C152H252N44O42
Form
Lyophilized powder

$45.00per vial

Price shown per vial. Quantity discounts below.

In stock

Amount per vial · 5 mg selected

Buy more, pay less per vial

Add 1 more vial to save 3%: $43.65 per vial.

  • Safe credit card paymentVisa, Mastercard and American Express
  • 30-day money-back guarantee
  • Super-fast 1-2 day shippingTo all 50 states and DC
  • Free shipping on orders over $200Applied automatically at checkout
Rated 4.9/5 on Trustpilot

CJC-1295 without DAC (Mod GRF 1-29)

5 mg · $45.00/vial

Lyophilized CJC-1295 without DAC storage

Keep sealed, dry and protected from light. Follow the label, SDS and lot-specific temperature and expiry instructions.

Reconstituted CJC-1295 without DAC storage

Validate solution stability for the experimental conditions.

CJC-1295 without DAC delivery and shipping

CJC-1295 without DAC ships from US stock to United States addresses only. Orders are packed and dispatched within 1-2 business days.

  • Standard: $9.95, 1-2 business days after dispatch.
  • Express: $24.95, next business day after dispatch.

Lyophilized CJC-1295 without DAC ships in a sealed glass vial with protective packaging. The dry powder is stable at room temperature for the length of domestic transit, so no cold pack is needed. Move it to the storage conditions above when it arrives.

Follow your parcel any time on the Track Order page.

CJC-1295 without DAC lab testing and COA

The certificate of analysis for CJC-1295 without DAC is being uploaded. Ask support for the current report before you order if you need it now.

Every vial label has a lot number. Check it on the Verify page to confirm the vial is genuine. All reports are on the Lab Reports page.

For laboratory research use only. All products are sold for laboratory research use only. They are not drugs, foods, cosmetics or dietary supplements, and are not for human or veterinary use.

CJC-1295 without DAC specifications

Product
CJC-1295 without DAC (Mod GRF 1-29)
Also known as
Mod GRF(1-29), Modified GRF 1-29
Compound class
GHRH Analogs & GH Secretagogues
Product type
Peptide
Form
Lyophilized powder
Amounts available
5 mg ($45.00), 10 mg ($79.00)
Chemical class
Tetrasubstituted GHRH(1-29) analogue
Peptide length
29 amino acids; C-terminal amide
Substitutions
D-Ala2, Gln8, Ala15 and Leu27 relative to GHRH(1-29)
Molecular formula
C152H252N44O42
Molecular weight
Approximately 3,367.95 g/mol (free peptide)
CAS number
446036-97-1 (non-DAC free form)[1]
Research focus
GHRH analogue chemistry; peptide identification
Storage as supplied
Sealed, dry, dark; -20 °C for long-term storage
Lab report
COA on request
Research areas
GHRH Analogs & GH Secretagogues, Popular Research Peptides
Intended use
Laboratory research only. Not for human or veterinary use.

Research overview

About CJC-1295 without DAC (Mod GRF 1-29)

Scientifically reviewed by John Johnson · Updated November 2026

CJC-1295 without DAC, commonly called modified GRF(1-29), is a synthetic 29-amino-acid GHRH analogue without the albumin-reactive DAC extension. It is supplied as a lyophilized powder for in vitro and analytical research involving peptide identity and GHRH-related signaling.[1][2]

The name refers to a modified fragment of growth hormone-releasing hormone, also called growth hormone-releasing factor. This material lacks the C-terminal albumin-reactive extension of CJC-1295 with DAC. The difference is chemically meaningful and should be explicit in the product identity.[1]

Names used in the CJC-1295 literature and marketplace are inconsistent. For research, the sequence, modification state, salt form and analytical report provide a more reliable description of the material than the abbreviated name alone.[1][2]

What Is CJC-1295 without DAC?

Modified GRF(1-29) contains the N-terminal 29-residue GHRH framework with four substitutions and a C-terminal amide. It does not contain the added maleimidopropionyl-lysine unit used for DAC-mediated albumin conjugation.[1]

The sequence is Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂. Full sequence information helps distinguish the tetrasubstituted peptide from native GHRH fragments and other analogues.[1]

CJC-1295 without DAC Research Applications

The non-DAC peptide is best described through its verified identity and carefully delimited research context:

  • Peptide identification: Using LC-HRMS/MS and sequence interpretation to characterize a 29-amino-acid, C-terminally amidated preparation marketed as CJC-1295. Henninge and colleagues provide a primary analytical example; the paper is not a clinical efficacy trial.[2]
  • GHRH analogue structure: Examining how the modified 29-residue core differs from native GHRH(1-29) and other related peptides. The four substitutions and absence of a DAC extension should be recorded when comparing materials.[1]
  • Proteolysis and analogue design: Using related GHRH studies to frame hypotheses about sequence modification. Soule and colleagues studied a D-Ala2 analogue in men; that singly substituted peptide is not the complete tetrasubstituted non-DAC product.[3]
  • Albumin-binding comparisons: Comparing a non-DAC material with a separately identified DAC-bearing reference when an experiment concerns albumin conjugation. The original CJC-1295 albumin work characterizes DAC derivatives and supplies mechanistic background, not direct non-DAC human evidence.[4]
  • Interpreting endocrine literature: Separating studies of the long-acting DAC compound from claims about modified GRF(1-29). The well-known healthy-adult CJC-1295 trial measured the DAC analogue; its multi-day exposure data do not characterize this product.[5]

Evidence in context. Direct human pharmacokinetic and clinical evidence for the exact non-DAC material is limited. Related-analogue studies and DAC studies should be labeled as such. A precise human half-life or a guaranteed brief GH pulse should not be assigned to this product from those sources.[1]c

Catalog and source notes

Catalog amounts / price5 mg: $45.00 | 10 mg: $79.00a
ShippingUS addresses only; listed dispatch time 1-2 business days. Standard shipping from $9.95.a
Lab reports / identityCOA on request. Use the vial lot number to request the matching analytical report and SDS.
Storage / handlingKeep sealed, dry and protected from light. Follow the label, SDS and lot-specific temperature and expiry instructions. Validate solution stability for the experimental conditions.

Catalog source: local CJC-1295 without DAC product page. Prices, availability and shipping terms may change. Confirm the current listing before ordering.

a. Vial sizes and commercial details reflect the local catalog on 12 November 2026; confirm the current listing and matching lot COA. b. Formula and mass describe the free peptide; counterions, water and other lot constituents are excluded. Confirm the supplied chemical form.

c. A related analogue or a DAC comparator is background evidence, not direct validation of the exact non-DAC sequence.

Laboratory research only. Chemical identity, circulating exposure and downstream GH secretion are separate research questions.

Sources and catalog checked 12 November 2026. Descriptive reference titles are labeled; article links identify the full publications.

Numbered citations throughout this description link directly to the sources below. Model notes identify the evidence each source provides.

CJC-1295 without DAC FAQ

Is CJC-1295 without DAC the same as modified GRF(1-29)?

Those names are commonly used for the 29-residue tetrasubstituted GHRH analogue without the DAC extension. Because naming is inconsistent, the lot-specific sequence and mass-spectrometry identity should confirm the actual material.[1][2]

What is the difference between the DAC and non-DAC forms?

The DAC form has an added C-terminal lysine carrying a reactive group for albumin conjugation. Modified GRF(1-29) lacks that extension. They are distinct molecules; their names should not be used interchangeably in a protocol or literature summary.[1]

Does without DAC mean unmodified GHRH?

No. The peptide still carries substitutions at positions 2, 8, 15 and 27 of the 29-residue GHRH framework. Without DAC means the albumin-reactive extension is absent. It does not mean that the core sequence is native GHRH.[1]

Is the non-DAC peptide the same as sermorelin?

No. Sermorelin is based on GHRH(1-29)-NH2, while modified GRF(1-29) has four substitutions. Findings for a native fragment, a D-Ala2 analogue and the tetrasubstituted material should be attributed to the compound actually studied.[1][3]

What is its human half-life?

The references cited here do not establish a precise human half-life for the exact non-DAC product. The 5.8-8.1-day figure often associated with CJC-1295 comes from the long-acting DAC study and should not be applied to modified GRF(1-29).[1]

Does a shorter exposure guarantee a more natural GH pulse?

No. Exposure duration and downstream secretion patterns are different questions. The available comparator papers do not demonstrate that a catalog non-DAC vial produces a particular human GH pulse or a clinical advantage. Such claims need direct evidence for the tested material.[1]

Is CJC-1295 without DAC approved for human use?

It is not an FDA-approved medicine. FDA has reviewed the DAC and non-DAC forms as distinct substances and has highlighted limited evidence and safety concerns in the CJC-1295 compounding context. This product is for laboratory research only.[1][6]

Scientific references

  1. [1]U.S. Food and Drug Administration (2024). CJC-1295-related bulk substances: scientific evaluation in the December 4 PCAC briefing document [descriptive title]. Chemistry, nomenclature and form-specific evidence. Open official source. Official distinction between DAC/non-DAC structures.
  2. [2]Henninge J, et al. (2010). Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug Test Anal. 2(11-12):647-650. doi: 10.1002/dta.233. Analytical identification of an amidated 29-residue peptide.
  3. [3]Soule S, King JA, Millar RP (1994). D-Ala2 substitution and GHRH(1-29) clearance in normal men [descriptive title]. J Clin Endocrinol Metab. 79(4):1208-1211. doi: 10.1210/jcem.79.4.7962295. Related singly substituted analogue; not this full sequence.
  4. [4]Jette L, et al. (2005). Albumin-linked hGRF(1-29) analogues and the identification of long-acting CJC-1295 [descriptive title]. Endocrinology. 146(7):3052-3058. doi: 10.1210/en.2004-1286. DAC chemistry and preclinical work; comparator context.
  5. [5]Teichman SL, et al. (2006). Prolonged GH and IGF-I stimulation with long-acting CJC-1295 in healthy adults [descriptive title]. J Clin Endocrinol Metab. 91(3):799-805. doi: 10.1210/jc.2005-1536. DAC human trial; not direct non-DAC pharmacokinetics.
  6. [6]U.S. Food and Drug Administration. Certain bulk drug substances for compounding that may present significant safety risks [descriptive title]. CJC-1295 entry; accessed 12 November 2026. Open official source. Official safety context; does not establish equivalence of forms.

Buying CJC-1295 without DAC for research in the USA

Price

From $45.00. 5 mg: $45.00, 10 mg: $79.00. Quantity discounts per size: 3% off 2 vials, 5% off 3-4 vials, 7% off 5+ vials.

Shipping

US addresses only. Orders are packed and dispatched within 1-2 business days. Standard from $9.95.

Proof it's genuine

Check the lot number on your vial on the Verify page.

Lab reports

COA and SDS documents are on the Lab Reports page.

Scientifically reviewed

Scientifically reviewed by John Johnson

Scientific reviewer · Last reviewed November 2026

John Johnson reviewed this CJC-1295 without DAC page for scientific accuracy: the compound's identity and specifications, the summaries of published studies, and the references they cite. The page describes laboratory and preclinical research only. It is not medical advice and gives no usage guidance.

Research information on this page summarizes published laboratory and preclinical studies. It is not usage guidance.

More in GHRH Analogs & GH Secretagogues

View all